Minimally invasive removal of deep contraceptive implants under continuous ultrasound guidance is effective, quick, and safe.

Contraception Contraceptive devices, female Foreign bodies Radiology, interventional Ultrasonography, interventional

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 12 05 2021
accepted: 18 08 2021
revised: 12 08 2021
pubmed: 16 10 2021
medline: 15 2 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

The aim of this study was to assess the feasibility, performance, and complications of a non-surgical, minimally-invasive procedure of deep contraceptive implant removal under continuous ultrasound guidance. The ultrasound-guided procedure consisted of local anesthesia using lidocaine chlorhydrate 1% (10 mg/mL) with a 21-G needle, followed by hydrodissection using NaCl 0.9% (9 mg/mL) and implant extraction using a Hartmann grasping microforceps. The parameters studied were the implant localization, success and complication rates, pain throughout the intervention, volumes of lidocaïne and NaCl used, duration of the procedure, and size of the incision. Between November 2019 and January 2021, 45 patients were referred to the musculoskeletal radiology department for ultrasound-guided removal of a deep contraceptive implant and were all retrospectively included. All implants were successfully removed en bloc (100%). The mean incision size was 2.7 ± 0.5 mm. The mean duration of the extraction procedure was 7.7 ± 6.3 min. There were no major complications (infection, nerve, or vessel damage). As a minor complication, 21 patients (46.7%) reported a benign superficial skin ecchymosis at the puncture site, spontaneously regressing in less than 1 week. The procedure was very well-tolerated, with low pain rating throughout (1.0 ± 1.5/10 during implant extraction). Minimally invasive removal of deep contraceptive implants under continuous ultrasound guidance alone is feasible, effective, and safe. In the present cohort, all implants were successfully removed, whatever the location, with short procedural time, small incision size, low pain levels, and no significant complications. This procedure could become a gold standard in this indication. • Minimally invasive removal of deep contraceptive implants under continuous ultrasound guidance alone is feasible, which led to a success rate of 100% whatever the location (even close to neurovascular structures), with only a small skin incision (2.7 ± 0.5 mm). • The procedure was safe, quick, without any major complications, and very well tolerated in terms of pain. • This minimally invasive ultrasound-guided procedure could become the future gold standard for the removal of deep contraceptive implants, as an alternative to surgical extraction, even for implants in difficult locations such as subfascial ones or those close to neurovascular structures.

Identifiants

pubmed: 34651210
doi: 10.1007/s00330-021-08263-4
pii: 10.1007/s00330-021-08263-4
pmc: PMC8831252
doi:

Substances chimiques

Contraceptive Agents 0
Lidocaine 98PI200987

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1718-1725

Informations de copyright

© 2021. The Author(s).

Références

Daniels K, Abma JC (2020) Current contraceptive status among women aged 15–49: United States, 2017–2019. NCHS Data Brief (388):1–8
Daniels K, Mosher WD (2013) Contraceptive methods women have ever used: United States, 1982–2010. Natl Health Stat Rep (62):1–15
CDC - National Center for Health Statistics Key Statistics from the National Survey of Family Growth - Contraception.  https://www.cdc.gov/nchs/nsfg/key_statistics/c_2015-2017.htm#contraception . Accessed 1 Oct 2021
United Nations, Department of Economic and Social Affairs Contraceptive Use by Method – 2019. https://www.un.org/en/development/desa/population/publications/pdf/family/ContraceptiveUseByMethodDataBooklet2019.pdf . Accessed 1 Oct 2021
Mommers E, Blum G-F, Gent TG, Peters KP, Sørdal TS, Marintcheva-Petrova M (2012) Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol 207:388.e1-388.e6
doi: 10.1016/j.ajog.2012.08.002
Palomba S, Falbo A, Di Cello A, Materazzo C, Zullo F (2012) Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecol Endocrinol 28:710–721
Reed S, Do Minh T, Lange JA, Koro C, Fox M, Heinemann K (2019) Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Contraception 100:31–36
pubmed: 30980829 doi: 10.1016/j.contraception.2019.03.052
Matulich MC, Chen MJ, Schimmoeller NR et al (2019) Referral center experience with nonpalpable contraceptive implant removals. Obstet Gynecol 134(4):801–806
pubmed: 31503148 pmcid: 6768758 doi: 10.1097/AOG.0000000000003457
Iwanaga J, Fox MC, Rekers H, Schwartz L, Tubbs RS (2019) Neurovascular anatomy of the adult female medial arm in relationship to potential sites for insertion of the etonogestrel contraceptive implant. Contraception 100:26–30
pubmed: 30858127 doi: 10.1016/j.contraception.2019.02.007
Sarma SP, Hatcher RP (1995) Neurovascular injury during removal of levonorgestrel implants. Am J Obstet Gynecol 172:120–121
pubmed: 7847517 doi: 10.1016/0002-9378(95)90096-9
Patel A, Shetty D, Hollings N, Dodds N (2014) Contraceptive implant embolism into the pulmonary artery. Ann Thorac Surg 97:1452
pubmed: 24694432 doi: 10.1016/j.athoracsur.2013.09.029
Barlow-Evans R, Jaffer K, Balogun M (2017) Migration of a Nexplanon contraceptive implant to the pulmonary artery. BMJ Case Rep 2017. https://doi.org/10.1136/bcr-2017-219259
Hindy J-R, Souaid T, Larus CT, Glanville J, Aboujaoude R (2020) Nexplanon migration into a subsegmental branch of the pulmonary artery: a case report and review of the literature. Medicine (Baltimore) 99:e18881
doi: 10.1097/MD.0000000000018881
Zhang S, Batur P, Martin C, Rochon PJ (2018) Contraceptive implant migration and removal by interventional radiology. Semin Interv Radiol 35:23–28
doi: 10.1055/s-0038-1636517
(1994) Inserting and removing levonorgestrel subdermal implants: an update. Contracept Rep 5:4–12
Pymar HC, Creinin MD, Schwartz JL (1999) “Pop-out” method of levonorgestrel implant removal. Contraception 59:383–387
pubmed: 10518233 doi: 10.1016/S0010-7824(99)00048-7
Lefebvre R, Hom M, Leland H, Stevanovic M (2018) Peripheral nerve injury with Nexplanon removal: case report and review of the literature. Contracept Reprod Med 3:15
pubmed: 30377538 pmcid: 6196439 doi: 10.1186/s40834-018-0070-0
Christensen JM, Caggiano NM, Giladi AM, Iorio ML (2018) Median nerve injury after removal of subdermal implantable contraceptive. Hand (N Y) 13:NP6–NP9
O’Grady EE, Power DM (2016) Ulnar nerve injury on removal of a contraceptive implant. Practitioner 260:21–24
pubmed: 29020717
Smith JM, Conwit RA, Blumenthal PD (1998) Ulnar nerve injury associated with removal of Norplant implants. Contraception 57:99–101
pubmed: 9589836 doi: 10.1016/S0010-7824(98)00007-9
Odom EB, Eisenberg DL, Fox IK (2017) Difficult removal of subdermal contraceptive implants: a multidisciplinary approach involving a peripheral nerve expert. Contraception 96:89–95
pubmed: 28583591 pmcid: 5555624 doi: 10.1016/j.contraception.2017.05.001
Shulman LP, Gabriel H (2006) Management and localization strategies for the nonpalpable Implanon rod. Contraception 73:325–330
pubmed: 16531160 doi: 10.1016/j.contraception.2005.10.009
Petro G, Spence T, Patel M, Gertz AM, Morroni C (2020) Difficult etonogestrel implant removals in South Africa: a review of 74 referred cases. Contraception 102:129–132
pubmed: 32339484 pmcid: 8221391 doi: 10.1016/j.contraception.2020.04.013
Lantz A, Nosher JL, Pasquale S, Siegel RL (1997) Ultrasound characteristics of subdermally implanted Implanon
pubmed: 9437562 doi: 10.1016/S0010-7824(97)00159-5
Vidin E, Garbin O, Rodriguez B, Favre R, Bettahar-Lebugle K (2007) Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception 76:35–39
pubmed: 17586134 doi: 10.1016/j.contraception.2007.03.012
Rivera F, Bianciotto A (2020) Contraceptive subcutaneous device migration: what does an orthopaedic surgeon need to know? A case report and literature review. Acta Biomed 91:232–237
Belyea C, Ernat J, Gumboc R (2017) Removal of a contraceptive implant from the brachial neurovascular sheath. J Hand Surg 42:e115–e117
doi: 10.1016/j.jhsa.2016.10.013
Jacques T, Henry S, Giraudet G, Demondion X, Cotten A (2020) Minimally-invasive fully ultrasound-guided removal of nonpalpable single-rod contraceptive implant: case report and technical description. Contraception 101(5):338–341
pubmed: 32032638 doi: 10.1016/j.contraception.2020.01.006
Cheng Z, Liang P (2019) US-guided core needle biopsy under assistance of hydrodissection to diagnose small lymph node metastases adjacent to cervical large vessels. Diagn Interv Radiol 25:122–126
pubmed: 30860075 pmcid: 6411263 doi: 10.5152/dir.2019.18166
Shiels WE, Babcock DS, Wilson JL, Burch RA (1990) Localization and guided removal of soft-tissue foreign bodies with sonography. AJR Am J Roentgenol 155:1277–1281
pubmed: 2122680 doi: 10.2214/ajr.155.6.2122680
Kim S, Choi YS, Kim JS, Kim S, Cho S (2019) Experiences of localization and removal of non-palpable subdermal contraceptive implants with ultrasound. Obstet Gynecol Sci 62:166
pubmed: 31139592 pmcid: 6520546 doi: 10.5468/ogs.2019.62.3.166
Nelson AL, Sinow RM (1998) Real-time ultrasonographically guided removal of nonpalpable and intramuscular Norplant capsules. Am J Obstet Gynecol 178:1185–1193
pubmed: 9662300 doi: 10.1016/S0002-9378(98)70321-7
Persaud T, Walling M, Geoghegan T, Buckley O, Stunell H, Torreggiani WC (2008) Ultrasound-guided removal of Implanon
pubmed: 18491101 doi: 10.1007/s00330-008-1055-1
Guiahi M, Tocce K, Teal S, Green T, Rochon P (2014) Removal of a Nexplanon® implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidance. Contraception 90:606–608
pubmed: 25081861 doi: 10.1016/j.contraception.2014.06.030
Chen MJ, Creinin MD (2015) Removal of a nonpalpable etonogestrel implant with preprocedure ultrasonography and modified vasectomy clamp. Obstet Gynecol 126:935–938
pubmed: 26444124 doi: 10.1097/AOG.0000000000001082

Auteurs

Thibaut Jacques (T)

Division of Musculoskeletal Radiology, Lille University Hospital Center, Centre de Consultations Et D'imagerie de L'appareil Locomoteur, Rue du Professeur Emile Laine, 59037, Lille Cedex, France. thibaut.jacques@chu-lille.fr.
Lille University School of Medicine, Lille, France. thibaut.jacques@chu-lille.fr.

Charlotte Brienne (C)

Division of Musculoskeletal Radiology, Lille University Hospital Center, Centre de Consultations Et D'imagerie de L'appareil Locomoteur, Rue du Professeur Emile Laine, 59037, Lille Cedex, France.
Lille University School of Medicine, Lille, France.

Simon Henry (S)

Division of Musculoskeletal Radiology, Lille University Hospital Center, Centre de Consultations Et D'imagerie de L'appareil Locomoteur, Rue du Professeur Emile Laine, 59037, Lille Cedex, France.

Hortense Baffet (H)

Division of Medical and Surgical Gynecology, Jeanne de Flandre Hospital, Lille University Hospital Center, Lille, France.

Géraldine Giraudet (G)

Division of Medical and Surgical Gynecology, Jeanne de Flandre Hospital, Lille University Hospital Center, Lille, France.

Xavier Demondion (X)

Division of Musculoskeletal Radiology, Lille University Hospital Center, Centre de Consultations Et D'imagerie de L'appareil Locomoteur, Rue du Professeur Emile Laine, 59037, Lille Cedex, France.
Lille University School of Medicine, Lille, France.

Anne Cotten (A)

Division of Musculoskeletal Radiology, Lille University Hospital Center, Centre de Consultations Et D'imagerie de L'appareil Locomoteur, Rue du Professeur Emile Laine, 59037, Lille Cedex, France.
Lille University School of Medicine, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH